Arrowhead Research | Beneficio Operativo



Operating Profit Cambio Fecha
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Arrowhead Research USD -161412000 791K 2024-12
Incyte USD 205.17M 96.34M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Ligand Pharmaceuticals USD -9637000 5.07B 2024-12
Merck USD 5.87B 1.57B 2025-03
Moderna USD -1050000000 196M 2025-03
Novartis USD 2.28B 1.34B 2024-12
Sarepta Therapeutics USD -300386000 462.07M 2025-03
TG Therapeutics USD 29.95M 17.52M 2024-12
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12
Xencor USD 4.05M 66.33M 2024-12



Arrowhead Research Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.